Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167427 · ClinicalTrials.gov registry record
Genotoxicity Assessment for Patients Undergoing Radiation Treatment
A clinical trial of Neoplasms, sponsored by Yuhchyau Chen.
- Completed
- Registry status
- 47
- Enrollment target
- 1
- Study location
NCT00167427 is a study of Neoplasms that has completed, run by Yuhchyau Chen. The registered enrollment target is 47 participants, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00167427, a study of Neoplasms, has completed, sponsored by Yuhchyau Chen.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research study is to evaluate an automated, laser-based technique for measuring DNA damage caused by radiation during cancer treatment in immature red blood cells.
Conditions Studied
Study Locations (1)
New York
- University of Rochester, Dept. Radiation Oncology - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2006-04 |
| Est. Completion | 2024-02-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167427
The ClinicalTrials.gov registry entry for NCT00167427 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (97% lower). The listed sponsor is Yuhchyau Chen, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT00167427 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00167427 about?
NCT00167427 is a clinical study titled "Genotoxicity Assessment for Patients Undergoing Radiation Treatment". The purpose of the research study is to evaluate an automated, laser-based technique for measuring DNA damage caused by radiation during cancer treatment in immature red blood cells.
What is the current status of trial NCT00167427?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2006-04. Estimated completion is 2024-02-23.
What conditions does trial NCT00167427 study?
This clinical trial studies the following conditions: Neoplasms.
Who is sponsoring clinical trial NCT00167427?
This trial is sponsored by Yuhchyau Chen, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00167427 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Resilience in East Asian Immigrants for Advance Care Planning Discussions
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.